ZA933178B - Pharmaceutical compositions of 5ht,-like receptor agonists for rectal administration - Google Patents

Pharmaceutical compositions of 5ht,-like receptor agonists for rectal administration

Info

Publication number
ZA933178B
ZA933178B ZA933178A ZA933178A ZA933178B ZA 933178 B ZA933178 B ZA 933178B ZA 933178 A ZA933178 A ZA 933178A ZA 933178 A ZA933178 A ZA 933178A ZA 933178 B ZA933178 B ZA 933178B
Authority
ZA
South Africa
Prior art keywords
pct
rectal administration
pharmaceutical compositions
receptor agonists
sec
Prior art date
Application number
ZA933178A
Other languages
English (en)
Inventor
Nadine Merlet
Isabelle Richard
Isabelle Thielemans
Original Assignee
Glaxo Lab Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Lab Sa filed Critical Glaxo Lab Sa
Publication of ZA933178B publication Critical patent/ZA933178B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
ZA933178A 1992-05-07 1993-05-06 Pharmaceutical compositions of 5ht,-like receptor agonists for rectal administration ZA933178B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929209882A GB9209882D0 (en) 1992-05-07 1992-05-07 Compositions

Publications (1)

Publication Number Publication Date
ZA933178B true ZA933178B (en) 1994-01-10

Family

ID=10715158

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA933178A ZA933178B (en) 1992-05-07 1993-05-06 Pharmaceutical compositions of 5ht,-like receptor agonists for rectal administration

Country Status (33)

Country Link
US (1) US5705506A (fr)
EP (1) EP0639072B1 (fr)
JP (1) JPH07506570A (fr)
KR (1) KR100253111B1 (fr)
AT (1) ATE163850T1 (fr)
AU (1) AU670083B2 (fr)
BE (1) BE1007024A5 (fr)
BG (1) BG62120B1 (fr)
BR (1) BR1100108A (fr)
CA (1) CA2135179C (fr)
CH (1) CH685920A5 (fr)
CY (1) CY2039B1 (fr)
CZ (1) CZ283512B6 (fr)
DE (1) DE69317418T2 (fr)
ES (1) ES2113533T3 (fr)
FR (1) FR2690847B1 (fr)
GB (2) GB9209882D0 (fr)
GR (1) GR3026584T3 (fr)
HK (1) HK95697A (fr)
HU (2) HU227338B1 (fr)
IE (1) IE75203B1 (fr)
IL (1) IL105468A (fr)
IT (1) IT1261471B (fr)
NO (1) NO306700B1 (fr)
NZ (1) NZ252132A (fr)
OA (1) OA10109A (fr)
RO (1) RO112993B1 (fr)
RU (1) RU2118527C1 (fr)
SG (1) SG46649A1 (fr)
TW (1) TW231970B (fr)
UA (1) UA37206C2 (fr)
WO (1) WO1993021916A1 (fr)
ZA (1) ZA933178B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997044062A1 (fr) * 1996-05-23 1997-11-27 Alcon Laboratories, Inc. Utilisation d'agonistes de 5-ht1b/1d dans le traitement de douleurs oculaires
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
PT1421939E (pt) * 1998-03-26 2010-07-12 Astellas Pharma Inc Preparaã†o da libertaã†o sustentada de um composto de macrëlido como tracolimus
AU3731400A (en) * 1999-03-05 2000-09-21 Trustees Of University Technology Corporation, The Methods and compositions useful in inhibiting apoptosis
ES2524556T3 (es) 2006-10-09 2014-12-10 Charleston Laboratories, Inc. Composiciones farmacéuticas
CA2905541C (fr) 2008-01-09 2020-02-11 Charleston Laboratories, Inc. Compositions pharmaceutiques renfermant un antiemetique et un analgesique opioide
WO2011006012A1 (fr) 2009-07-08 2011-01-13 Charleston Laboratories Inc. Compositions pharmaceutiques
HUE031661T2 (en) 2010-10-15 2017-07-28 Contera Pharma Aps Combinations of serotonin receptor agonists for the treatment of movement disorders
NZ700474A (en) 2012-04-18 2016-10-28 Contera Pharma Aps Orally available pharmaceutical formulation suitable for improved management of movement disorders
EP3423041A4 (fr) 2016-03-04 2019-09-11 Charleston Laboratories, Inc. Compositions pharmaceutiques
CN109689036A (zh) 2016-07-11 2019-04-26 康特拉医药公司 用于治疗早晨运动不能的脉冲药物输送系统

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2082175B (en) * 1980-08-12 1984-05-02 Glaxo Group Ltd Heterocyclic compounds
FR2488606A1 (fr) * 1980-08-12 1982-02-19 Glaxo Group Ltd Derives indoliques, leur preparation et leurs applications en tant que medicaments
ZW19381A1 (en) * 1980-08-12 1983-03-09 Glaxo Group Ltd Heterocyclic compounds
IT1170387B (it) * 1982-06-07 1987-06-03 Glaxo Group Ltd Composti eterociclici, procedimento per prepararli e composizioni farmaceutiche che li contengono
GB8332435D0 (en) * 1983-12-06 1984-01-11 Glaxo Group Ltd Chemical compounds
GB8419575D0 (en) * 1984-08-01 1984-09-05 Glaxo Group Ltd Chemical compounds
GB2162522B (en) * 1984-08-01 1988-02-24 Glaxo Group Ltd An indole derivative
AU584142B2 (en) * 1984-12-04 1989-05-18 Glaxo Group Limited Indole derivatives
GB8431426D0 (en) * 1984-12-13 1985-01-23 Glaxo Group Ltd Chemical compounds
DE3678805D1 (de) * 1985-11-08 1991-05-23 Glaxo Group Ltd Indolderivate.
GB2208646B (en) * 1987-08-13 1991-06-26 Glaxo Group Ltd Indole derivatives
IL114690A (en) * 1990-06-07 1997-02-18 Wellcome Found Antimigraine oxazolidinone substituted indole derivatives

Also Published As

Publication number Publication date
SG46649A1 (en) 1998-02-20
WO1993021916A1 (fr) 1993-11-11
HU227338B1 (en) 2011-04-28
HK95697A (en) 1997-08-08
NO306700B1 (no) 1999-12-13
UA37206C2 (uk) 2001-05-15
GB2266665B (en) 1996-05-22
GB9209882D0 (en) 1992-06-24
HU211638A9 (en) 1995-12-28
DE69317418D1 (de) 1998-04-16
GR3026584T3 (en) 1998-07-31
HUT71418A (en) 1995-11-28
BG62120B1 (bg) 1999-03-31
CH685920A5 (fr) 1995-11-15
CZ272394A3 (en) 1995-10-18
FR2690847B1 (fr) 1995-06-09
NO944214L (no) 1994-11-07
KR100253111B1 (en) 2000-07-01
IT1261471B (it) 1996-05-23
EP0639072B1 (fr) 1998-03-11
OA10109A (en) 1996-12-18
ITRM930286A1 (it) 1994-11-06
BE1007024A5 (fr) 1995-02-21
JPH07506570A (ja) 1995-07-20
IL105468A0 (en) 1993-08-18
IE930339A1 (en) 1993-11-17
EP0639072A1 (fr) 1995-02-22
BG99167A (bg) 1995-06-30
ATE163850T1 (de) 1998-03-15
RO112993B1 (ro) 1998-03-30
CA2135179C (fr) 2000-12-05
DE69317418T2 (de) 1998-07-30
CA2135179A1 (fr) 1993-11-11
NO944214D0 (no) 1994-11-04
IL105468A (en) 1998-09-24
CY2039B1 (en) 1998-04-30
IE75203B1 (en) 1997-08-27
AU4064093A (en) 1993-11-29
GB2266665A (en) 1993-11-10
NZ252132A (en) 1996-09-25
FR2690847A1 (fr) 1993-11-12
AU670083B2 (en) 1996-07-04
BR1100108A (pt) 1999-12-07
US5705506A (en) 1998-01-06
TW231970B (fr) 1994-10-11
GB9309209D0 (en) 1993-06-16
RU2118527C1 (ru) 1998-09-10
ITRM930286A0 (it) 1993-05-06
CZ283512B6 (cs) 1998-04-15
ES2113533T3 (es) 1998-05-01

Similar Documents

Publication Publication Date Title
NZ315740A (en) Oral fast-dissolving compositionsfor dopamine agonists
ATE331726T1 (de) Adenine-derivate
AP2001002129A0 (en) 5HT1 receptor agonists and metoclopramide for the treatment of migrane.
MY117274A (en) Polycyclic amine compounds and their enantiomers,their method of preparation and pharmaceutical compositions in which they are present.
MX9702865A (es) Agentes estrogenicos.
DK0641328T3 (da) Broforbundne, azabicykliske derivater som substans P-antagonister
MY136249A (en) Phenylethanolamine compounds as anti-obesity agents
ZA971279B (en) Use of 5ht4 receptor antagonists for overcoming gastrointestinal effects of serotonin reuptake inhinitors
ZA933178B (en) Pharmaceutical compositions of 5ht,-like receptor agonists for rectal administration
MXPA03000548A (es) Combinacion novedosa de agonista (5-ht2) y antagonistas (5-ht6) de serotonina como formulacion farmaceutica.
IL114600A (en) Thiazole and thiadiazole compounds their preparation and pharmaceutical compositions containing them
IL114598A (en) Triazole compounds their preparation and pharmaceutical compositions containing them
GR3022615T3 (en) Pharmaceutical compositions based on ebastime or analogues thereof.
WO2000000198A8 (fr) Derives de piperidine agissant sur les systemes lies a la serotonine
EP1064966A3 (fr) Combinaisons d'agonistes de recepteurs de 5HT 1, de cafeine et d'inhibiteurs de cyclooxygenase-2 pour le traitement de la migraine
GR3036195T3 (en) Novel compounds
BG102229A (en) Endothelium receptor antagonists
EP1064948A3 (fr) Combinaisons d'agonistes de recepteurs de 5HT 1, de cafeine et d'inhibiteurs de cyclooxygenase-2 pour le traitement de la migraine
EP1051994A3 (fr) Agonistes de récepteur de 5HT 1 et un inhibiteur de la cyclooxygénase-2 pour le traitment de la migraine